Pharmaceutical use of N-carbamoylazole derivatives
申请人:——
公开号:US20030060494A1
公开(公告)日:2003-03-27
The present invention relates to use of 1-carbamoylazole derivatives as medicaments and pharmaceutical compositions containing 1-carbamoylazole derivatives as the active ingredient, based on their DPPIV inhibiting effects. The present invention provides a dipeptidyl peptidase IV inhibiting agent comprising a compound represented by the general formula (I):
1
The use of, as a reaction solvent in the reaction of a 1,3,5-trialkyl-2-halogenobenzene and an alkali metal salt of 3-mercapto-1H-1,2,4-triazole in the presence of a copper catalyst for the preparation of a 3-(2,4,6-trialkylphenylthio)-1H-1,2,4-triazole useful as an intermediate in the preparation of herbicide compounds, a compound represented by the general formula
in which R is a lower alkyl group, Y is a methylene group or an N-(lower alkyl)imino group and Z is a divalent hydrocarbon group to form a 5-membered ring or 6-membered ring together with the group -N-CO-Y-, such as N-methyl-2-pyrrolidone, N,N'-dimethyl-2-imidazolidinone and N,N'-dimethyl propylene urea, gives the product in high yield without the danger of explosion.